Avsar.

Healthcare · Healthcare Service Provider

Metropolis Healthcare Ltd (METROPOLIS)

₹570.25

Mkt cap
₹11,823 Cr
P/E ratio
60.20
P/B
7.81
Div yield
0.35%
ROE
13.80%
ROCE
17.80%
EPS (TTM)
₹9.47
Book value
₹73
52W range
422–578
Sector
Healthcare

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

NSE METROPOLISBSE 542650www.metropolisindia.com
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsBullish
52-week range
−1.42% from high
₹570
₹422+35.21% from low₹578
Current
₹570.25
Prev close
₹575.00
Day
−0.83%
Price performance
1D
−0.83%
1W
−0.61%
1M
+4.95%
3M
+22.08%
6M
+19.45%
1Y
+16.26%
YTD
+17.98%

Financials

F
Revenue, profit & margin
P/E ratio
60.2×
METROPOLIS is 27% above the sector median of 47.4×
METROPOLIS60.2×
Sector median47.4×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales283277308291331313350323345386429406425
Expenses212214234226251235260251283296321311317
Operating Profit7063756580799072629010895108
OPM %25%23%24%22%24%25%26%22%18%23%25%23%25%
Other Income13123233781-08
Interest6665655555668
Depreciation23212225262627282931323239
Profit before tax42394837515161423661715770
Tax %20%26%26%26%28%25%24%26%19%26%26%26%27%
Net Profit33293627373847312945534251
EPS in Rs1.631.411.731.331.781.852.271.531.412.172.542.002.46
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Jun 2026
48.86%Promoter
Promoters48.86%
FIIs11.03%0.60
DIIs35.12%0.68
Public5.00%0.08
Ownership trend

Peers

P7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Dr Lal Pathlabs₹1,759.2052.4529,4910.80%171+28.02%798+19.10%28.00%
Vijaya Diagnost.₹1,313.9078.2313,5330.15%48+34.56%219+26.63%21.29%
Metropolis Healt₹570.2560.2011,8230.35%51+74.43%425+22.99%17.77%
Thyrocare Tech.₹564.2549.698,9811.65%51+34.06%240+24.34%35.38%
Nephrocare Health Services₹673.1090.376,7690.00%30+22.11%266+21.18%15.34%
Krsnaa Diagnost.₹544.8017.211,7670.50%43+105.89%173−0.93%12.70%
Suraksha Diagno.₹252.9540.931,3170.20%6−15.02%81+25.07%16.97%
Median: 14 Co.₹554.5247.421,2350.07%14+25.80%153+22.09%22.28%

Filings

D
Annual reports7
Financial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bse
Concall transcripts73
TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025PPTOct 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptDec 2024PPTDec 2024TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024
Credit ratings6
Rating update 24 Sep 2025crisilRating update 27 Sep 2024crisilRating update 17 Sep 2024crisilRating update 3 Oct 2023crisilRating update 10 Oct 2022crisilRating update 20 Oct 2021crisil
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 14hAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 9 Jul - Allotment of 36,900 equity shares under the Metropolis- Restrictive Stock Unit Plan, 2020Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jul - Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026Business Update For Q1FY27 5 Jul - Q1FY27 business update: revenue up 16% YoY, margins improved, results pending board approval.Closure of Trading Window 29 Jun - Trading window closed from June 30, 2026 until 48 hours after Q1 FY27 results.